Literature DB >> 7626017

Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.

W B Valhmu1, G D Palmer, P A Rivers, S Ebara, J F Cheng, S Fischer, A Ratcliffe.   

Abstract

The complete exon-intron organization of the human aggrecan gene has been defined, and the exon organization has been compared with the individual domains of the protein core. A yeast artificial chromosome containing the aggrecan gene was selected from the Centre d'Etude du Polymorphisme Humaine yeast artificial chromosome library. A cosmid sulibrary was created from this, and direct sequencing of individual cosmids was used to provide the exon-intron organization. The human aggrecan gene was found to be composed of 19 exons ranging in size from 77 to 4224 bp. Exon 1 is non-coding, whereas exons 2-19 code for a protein core of 2454 amino acids with a calculated mass of 254379 Da. Intron 1 of the gene is at least 13 kb. Overall, the sizes of the 18 introns range from 0.5 to greater than 13 kb. Each intron begins with a GT and ends with an AG, thus obeying the GT/AG rule of splice-junction sequences. The entire coding region is contained in 39.4 kb of the gene. The organization of exons is strongly related to the specific domains of the protein core. The A loop of G1 and the interglobular domain are encoded by exons 3 and 7 respectively. The B and B' loops of G1 are encoded by exons 4-6, and those of G2 are encoded by exons 8-10. These sets of exons, coding for the B and B' loops, are identical in size and organization. This is supported by the intron classes associated with these exons. Exon 11 codes for the 5' half of the keratan sulphate-rich region, and exon 12 codes for the 3' half of the keratan sulphate-rich region as well as the entire chondroitin sulphate-rich region. G3 is encoded by exons 13-18, including the alternatively spliced epidermal growth factor-like and complement regulatory protein-like domains. The correspondence between the exon organization and the protein domains argues strongly for modular assembly of the aggrecan gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626017      PMCID: PMC1135764          DOI: 10.1042/bj3090535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  69 in total

1.  DNA of Saccharomyces cerevisiae.

Authors:  P Philippsen; A Stotz; C Scherf
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Key residues involved in calcium-binding motifs in EGF-like domains.

Authors:  P A Handford; M Mayhew; M Baron; P R Winship; I D Campbell; G G Brownlee
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

3.  Evolutionary conservation of intron position in a subfamily of genes encoding carbohydrate-recognition domains.

Authors:  K Bezouska; G V Crichlow; J M Rose; M E Taylor; K Drickamer
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

4.  Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family.

Authors:  H Yamada; K Watanabe; M Shimonaka; Y Yamaguchi
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

5.  The structure of the rat aggrecan gene and preliminary characterization of its promoter.

Authors:  K J Doege; K Garrison; S N Coulter; Y Yamada
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

6.  Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1.

Authors:  T Collins; A Williams; G I Johnston; J Kim; R Eddy; T Shows; M A Gimbrone; M P Bevilacqua
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

7.  Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene.

Authors:  H Watanabe; K Kimata; S Line; D Strong; L Y Gao; C A Kozak; Y Yamada
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

8.  Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele.

Authors:  D P Vik; W W Wong
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

9.  Modulation of native chondroitin sulphate structure in tissue development and in disease.

Authors:  B Caterson; F Mahmoodian; J M Sorrell; T E Hardingham; M T Bayliss; S L Carney; A Ratcliffe; H Muir
Journal:  J Cell Sci       Date:  1990-11       Impact factor: 5.285

10.  BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain.

Authors:  D M Jaworski; G M Kelly; S Hockfield
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

View more
  19 in total

1.  Domain shuffling and the evolution of vertebrates.

Authors:  Takeshi Kawashima; Shuichi Kawashima; Chisaki Tanaka; Miho Murai; Masahiko Yoneda; Nicholas H Putnam; Daniel S Rokhsar; Minoru Kanehisa; Nori Satoh; Hiroshi Wada
Journal:  Genome Res       Date:  2009-05-14       Impact factor: 9.043

2.  Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan.

Authors:  C Fülöp; G Cs-Szabó; T T Glant
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis.

Authors:  Lindsay Gleghorn; Rajkumar Ramesar; Peter Beighton; Gillian Wallis
Journal:  Am J Hum Genet       Date:  2005-07-22       Impact factor: 11.025

4.  Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.

Authors:  L A West; P Roughley; F R Nelson; A H Plaas
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

5.  Quantification of aggrecan and link-protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR.

Authors:  M C Bolton; J Dudhia; M T Bayliss
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

6.  Aggrecan: A Target Molecule of Autoimmune Reactions.

Authors:  Edit I Buzás; Katalin Mikecz; Tibor T Glant
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

7.  Identification of a locus for a form of spondyloepiphyseal dysplasia on chromosome 15q26.1: exclusion of aggrecan as a candidate gene.

Authors:  S Eyre; P Roby; K Wolstencroft; K Spreckley; R Aspinwall; R Bayoumi; L Al-Gazali; R Ramesar; P Beighton; G Wallis
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

Review 8.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

9.  Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.

Authors:  F H Büttner; C E Hughes; D Margerie; A Lichte; H Tschesche; B Caterson; E Bartnik
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

10.  L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.

Authors:  Yu Han; Véronique Lefebvre
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.